Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Activist Push Has Telenav Popping As Fund Seeks Board Seats

Page 1 of 2

Brett Hendrickson‘s Nokomis Capital has steeped up its interest in Telenav Inc (NASDAQ:TNAV) and is now seeking representation on the company’s Board of Directors. As reported in a recent filing with the Securities and Exchange Commission, Nokomis Capital has nominated Richard L. Todaro and Mikel H. Williams for election to the company’s board at its 2015 annual shareholder meeting, on behalf of the fund. In addition, Hendrickson has boosted his stake in Telenav to approximately 3.68 million shares from 3.48 million shares previously reported, thus taking control of 9.1% of the company’s common stock. Shares of Telenav have jumped by nearly 9% in today’s session.


As the financial world was melting down at the height of the 2008 crisis, Brett Hendrickson managed to raise $4 million from his family and friends to start Nokomis Capital. Hendrickson invests mainly in companies that have solid cash flow and good profit margins, and tends to favor companies that “make things you can touch and feel.” He employs a fundamental approach to picking his targets and goes both long and short, although he’s got a preference for the latter. His philosophy has paid off handsomely, as Nokomis’ public equity portfolio carried a market value of $362 million at the end of the second quarter.

Brett Hendrickson
Brett Hendrickson
Nokomis Capital

Let’s first take a step back and analyze how tracking hedge funds can help an everyday investor. Through our research we discovered that a portfolio of the 15 most popular small-cap picks of hedge funds beat the S&P 500 Total Return Index by nearly a percentage point per month on average between 1999 and 2012. On the other hand the most popular large-cap picks of hedge funds underperformed the same index by seven basis points per month during the same period. This is likely a surprise to many investors, who think of small-caps as risky, unpredictable stocks and put more faith (and money) in large-cap stocks. In forward tests since August 2012 these top small-cap stocks beat the market by an impressive 60.4 percentage points, returning 118% (read the details here). Follow the smart money into only their best investment ideas all while avoiding their high fees.

Hendrickson has acquired a taste for tech stocks lately, with roughly half of his capital being invested in companies from this sector. A notable play is NeoPhotonics Corp (NYSE:NPTN), a producer of circuits used in communications devices that was added to Nokomis’ portfolio during the second quarter. Hendrickson bought exactly 1.95 million shares, making it a top investment along with RealD (NYSE:RLD), the producer of 3D and other visual technologies. According to its latest 13F filing, Nokomis holds 1.58 million shares of RealD, up by 9% during the quarter. Kirkland’s, Inc. (NASDAQ:KIRK) has fallen out of Hendrickson’s favor, having reduced his exposure to the company for the third straight quarter, to 913,859 shares.

A producer of navigation systems and software, Telenav Inc (NASDAQ:TNAV) has a market cap of $293 million and does not pay a dividend. While Chuck Royce was cutting his holding in the company by 6% to 412,300 shares during the second quarter, Richard Driehaus decided it was a good time to join the party and initiated a position. His fund, Driehaus Capital, holds 312,109 shares according to its latest quarterly filing.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!